Stratos Wealth Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $446K | Buy |
1,594
+29
| +2% | +$7.62K | ﹤0.01% | 1198 |
|
|
2026
Q1 | $418K | Sell |
1,565
-472
| -23% | -$128K | ﹤0.01% | 1142 |
|
|
2025
Q4 | $511K | Buy |
2,037
+218
| +12% | +$57.9K | 0.01% | 1038 |
|
|
2025
Q3 | $522K | Buy |
1,819
+510
| +39% | +$137K | 0.01% | 1001 |
|
|
2025
Q2 | $344K | Buy |
1,309
+2
| +0.2% | +$487 | ﹤0.01% | 1084 |
|
|
2025
Q1 | $304K | Buy |
1,307
+39
| +3% | +$9.46K | ﹤0.01% | 1090 |
|
|
2024
Q4 | $291K | Buy |
1,268
+134
| +12% | +$30.7K | ﹤0.01% | 1156 |
|
|
2024
Q3 | $253K | Sell |
1,134
-230
| -17% | -$50.6K | ﹤0.01% | 1231 |
|
|
2024
Q2 | $278K | Buy |
+1,364
| New | +$277K | ﹤0.01% | 1116 |
|
|
2023
Q1 | – | Sell |
-1,037
| Closed | -$210K | – | 1187 |
|
|
2022
Q4 | $210K | Sell |
1,037
-204
| -16% | -$39.9K | 0.01% | 1021 |
|
|
2022
Q3 | $218K | Sell |
1,241
-59
| -5% | -$12.1K | 0.01% | 995 |
|
|
2022
Q2 | $262K | Sell |
1,300
-8,792
| -87% | -$1.87M | 0.01% | 990 |
|
|
2022
Q1 | $2.29M | Buy |
10,092
+699
| +7% | +$164K | 0.05% | 329 |
|
|
2021
Q4 | $2.54M | Buy |
9,393
+771
| +9% | +$191K | 0.06% | 302 |
|
|
2021
Q3 | $2.08M | Buy |
8,622
+1,484
| +21% | +$374K | 0.05% | 306 |
|
|
2021
Q2 | $1.69M | Buy |
+7,138
| New | +$1.63M | 0.04% | 392 |
|
|
2020
Q4 | – | Sell |
-1,257
| Closed | -$203K | – | 1099 |
|
|
2020
Q3 | $203K | Buy |
+1,257
| New | +$199K | 0.01% | 917 |
|
|
2018
Q4 | – | Sell |
-2,277
| Closed | -$340K | – | 1761 |
|
|
2018
Q3 | $340K | Sell |
2,277
-5,618
| -71% | -$855K | 0.02% | 664 |
|
|
2018
Q2 | $1.22M | Sell |
7,895
-108
| -1% | -$16.3K | 0.05% | 318 |
|
|
2018
Q1 | $1.11M | Buy |
8,003
+55
| +0.7% | +$8.08K | 0.05% | 344 |
|
|
2017
Q4 | $1.09M | Buy |
+7,948
| New | +$1.05M | 0.05% | 333 |
|
|
2016
Q3 | – | Sell |
-4,875
| Closed | -$546K | – | 703 |
|
|
2016
Q2 | $546K | Buy |
+4,875
| New | +$525K | 0.04% | 319 |
|
|
2015
Q4 | – | Sell |
-2,570
| Closed | -$240K | – | 615 |
|
|
2015
Q3 | $240K | Buy |
+2,570
| New | +$266K | 0.03% | 434 |
|
|
2015
Q2 | – | Sell |
-2,671
| Closed | -$293K | – | 580 |
|
|
2015
Q1 | $293K | Buy |
2,671
+306
| +13% | +$31.5K | 0.03% | 434 |
|
|
2014
Q4 | $219K | Buy |
+2,365
| New | +$209K | 0.04% | 422 |
|
Other funds holding LH
Stratos Wealth Partners's LH Position: Q2 2026 in Review
Stratos Wealth Partners increased its Labcorp (LH) stake by 1.9% in Q2 2026, buying an estimated $7.62K and bringing the position to 1,594 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.
Stratos Wealth Partners first reported a position in LH in Q4 2014 and has held it in 25 quarters since. The position peaked at $2.54M in Q4 2021. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Stratos Wealth Partners held 1,594 shares of Labcorp worth $446K as of Q2 2026.
- Stratos Wealth Partners bought 29 Labcorp shares in Q2 2026, an estimated $7.62K.
- Labcorp made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #1198 holding.
- Stratos Wealth Partners first reported a position in Labcorp in Q4 2014 and has held it in 25 quarters since.
- Stratos Wealth Partners's Labcorp position peaked at $2.54M in Q4 2021.
- 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.